Pilot Study: Acai May Lower Risk of Metabolic Syndrome

June 14, 2011

The study involved 10 overweight but healthy adults who consumed 100 g of Sambazon-brand acai frozen fruit pulp twice daily before meals.

Acai may help reduce certain risk factors associated with metabolic syndrome, including heart disease, diabetes, and stroke, according to a pilot study published in May in Nutrition Journal.

The study involved 10 overweight but healthy adults who consumed 100 g of Sambazon-brand acai frozen fruit pulp twice daily before meals, for four weeks. After 30 days, the researchers said they found reductions in fasting glucose, postprandial increases in blood glucose, insulin, total cholesterol, and low-density lipoprotein cholesterol.

“This pilot study demonstrates the ability of Sambazon’s acai pulp to significantly lower several markers of cardiovascular risk in a relatively short period of time,” stated Jay Udani, MD, CEO and medical director of Medicus Research, which conducted the study. “These positive results are in line with prior studies and warrant further study on the acai berry’s ability to promote cardiovascular and metabolic health.”